AVNS
Avanos Medical, Inc.Company with tickers: AVNS
CIK
1606498
CUSIP
05350V106
Shares Outstanding
46,824,793
13F Activity (30d)
183 filings
177 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $182,200,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | $94,200,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Expenses | — | ||||
| Research & Development | $5,200,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $8,900,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $5,100,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |